Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes

Virus Research

Volumn 60, Issue 2, 1999, Pages 159-169

  Ibrahim, Jamal ^a   Griffin, Philip ^a   Coombe, Deirdre R ^b   Rider, Christopher C ^c   James, William ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Heparan sulfate; HIV 1 entry; Receptor

Indexed keywords

CELL SURFACE RECEPTOR; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN LYASE;

ARTICLE; CELL LINE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS STRAIN;

CELL LINE; CHLORATES; CULTURE MEDIA; HELA CELLS; HEPARITIN SULFATE; HERPESVIRUS 1, HUMAN; HIV-1; HUMANS; LYMPHOCYTES; MONOCYTES; POLYSACCHARIDE-LYASES; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED;

EID: 0033013344     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(99)00018-0     Document Type: Article

References (51)

1. Berger E.A., Doms R.W., Fenyo E.-M., Korber B.T.M., Littman D.R., Moore J.P., Sattentau Q.J., Schuitemaker H., Sodroski J., Weiss R.A. A new classification for HIV-1. Nature. 391:1998;240.
2. Blumenkrantz N., Asboe-Hansen G. New method for quantitative determination of uronic acids. Anal. Biochem. 54:1973;484-489.
3. Callahan L.N., Phelan M., Mallinson M., Norcross M.A. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions. J. Virol. 65(3):1991;1543-1550.
4. Chang H.C., Samaniego F., Nair B.C., Buonaguro L., Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. Aids. 11(12):1997;1421-1431.
5. Chen Y., Maguire R.E., Fromm J.R., Esko J.D., Lindhardt R.J., Marks R.M. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3(8):1997;866-871.
6. Collin M., Gordon S. The kinetics of HIV reverse transcription are slower in primary human macrophages than in a lymphoid cell line. Virology. 200:1994;114-120.
7. Collin M., James W., Gordon S. Development of techniques to analyse the formation of HIV provirus in primary human macrophages. Res. Virol. 142(2-3):1991;105-112.
8. Collin M., Illei P., James W., Gordon S. Definition of the range and distribution of HIV macrophage tropism using PCR-based infectivity measurements. J. Gen. Virol. 75:1994;1597-1603.
9. de Madrid A., Porterfield J. A simple micro-culture method for the study of group B arboviruses. Bull. World Health Org. 40:1969;113-121.
10. Gartner S., Markovits P., Markovitz D.M., Kaplan M.H., Gallo R.C., Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science. 233(4760):1986;215-219.
11. Gey G.O., Coffman W.D., Kubicek M.T. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12:1952;264-265.
12. Gregory S., Collman R., James W., Gordon S., Gonzalez-Scarano F., Nathanson N. HIV-1 pseudotype virus containing a Cocal virus genome and an HIV envelope: construction, assay and use. J. Virol. Met. 44:1993;287-304.
13. Gregory, S., James, W., Nathanson, N., 1994. Construction, assay, and use of pseudotype viruses between HIV and Cocal, a Vesiculovirus. In: Adolph, K. (Ed.), Molecular Virology Techniques Part A, Vol. 4, 5 vols. Academic Press, San Diego, pp. 76-85.
14. Greve H., Cully Z., Blumberg P., Kresse H. Influence of chlorate on proteoglycan biosynthesis by cultured human fibroblasts. J. Biol. Chem. 263:1988;12886-12892.
15. Gruenheid S., Gatzke L., Meadows H., Tufaro F. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J. Virol. 67(1):1993;93-100.
16. Herold B.C., WuDunn D., Soltys N., Spear P.G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65(3):1991;1090-1098.
17. Herold B.C., Visalli R.J., Susmarski N., Brandt C.R., Spear P.G. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J. Gen. Virol. 75(6):1994;1211-1222.
18. Humphries D.E., Sugumaran G., Silbert J.E. Decreasing sulfation of proteoglycans produced by cultured cells. Methods Enzymol. 179:1989;428-434.
19. Ianelli C.J., DeLellis R., Thorley-Lawson D.A. CD48 binds to heparan sulfate on the surface of epithelial cells. J. Biol. Chem. 273(36):1998;23367-23375.
20. Ito M., Baba M., Sato A., Pauwels R., De C.E., Shigeta S. Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Antiviral Res. 7(6):1987;361-367.
21. Jackson D.G., Bell J.I., Dickinson R., Timans J., Shields J., Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the V3 exon. J. Cell Biol. 128(4):1995;673-685.
22. Karger A., Saalmuller A., Tufaro F., Banfield B.W., Mettenleiter T.C. Cell surface proteoglycans are not essential for infection by pseudorabies virus. J. Virol. 69(6):1995;3482-3489.
23. Keller K.M., Brauer P.R., Keller J.M. Modulation of cell surface heparan sulphate structure by growth of cells in the presence of chlorate. Biochemistry. 28:1989;8100-8107.
24. Koopmann W., Krangel M.S. Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1alpha. J. Biol. Chem. 272(15):1997;10103-10109.
25. Krusat T., Streckert H.J. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch. Virol. 142(6):1997;1247-1254.
26. Lycke E., Johansson M., Svennerholm B., Lindahl U. Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J. Gen. Virol. 72:1991;1131-1137.
27. Maddon P.J., Dalgleish A.G., McDougal J.S., Clapham P.R., Weiss R.A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 47(3):1986;333-348.
28. McClain D.S., Fuller A.O. Cell-specific kinetics and efficiency of herpes simplex virus type 1 entry are determined by two distinct phases of attachment. Virology. 198(2):1994;690-702.
29. Mondor I., Ugolini S., Sattentau Q.J. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 72(5):1998;3623-3634.
30. Montgomery R.I., Warner M.S., Lum B.J., Spear P.G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell. 87(3):1996;427-436.
31. Ohshiro Y., Murakami T., Matsuda K., Nishioka K., Yoshida K., Yamamoto N. Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection. Microbiol. Immunol. 40(11):1996;827-835.
32. Oravecz T., Pall M., Wang J., Roderiquez G., Ditto M., Norcross M.A. Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans. J. Immunol. 159(9):1997;4587-4592.
33. Patel M., Yanagishita M., Roderiquez G., Bou H.D., Oravecz T., Hascall V.C., Norcross M.A. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. Aids Res. Hum. Retroviruses. 9(2):1993;167-174.
34. Popovic M., Sarngadharan M.G., Read E., Gallo R.C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 224(4648):1984;497-500.
35. Roderiquez G., Oravecz T., Yanagishita M., Bou-Habib D.C., Mostowski H., Norcross M.A. Mediation of HIV-1 binding by interaction of cell surface heparan sulphate proteoglycans with the V3 region of envelope gp120-gp41. J. Virol. 69:1995;2233-2239.
36. Salahuddin S.Z., Markham P.D., Wong S.F., Franchini G., Kalyanaraman V.S., Gallo R.C. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology. 129(1):1983;51-64.
37. Shieh M.T., Spear P.G. Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin. J. Virol. 68(2):1994;1224-1228.
38. Shieh M.T., WuDunn D., Montgomery R.I., Esko J.D., Spear P.G. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell. Biol. 116(5):1992;1273-1281.
39. Simon J., Somoza C., Schockmel G., Collin M., Davis S., Williams A., James W. A rat CD4 mutant containing the gp120-binding site mediates HIV-1 infection. J. Exp. Med. 177:1993;949-954.
40. Simon J., Schockmel G., Illei P., James W. A rodent cell line permissive for entry and reverse transcription of HIV-1 has a pre-integration block to productive infection. J. Gen. Virol. 75:1994;2615-2623.
41. Spear P.G., Shieh M.T., Herold B.C., WuDunn D., Koshy T.I. Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv. Exp. Med. Biol. 313(341):1992;341-353.
42. Stringer S.E., Gallagher J.T. Specific binding of the chemokine platelet factor 4 to heparan sulfate. J. Biol. Chem. 272(33):1997;20508-20514.
43. Svennerholm B., Jeansson S., Vahlne A., Lycke E. Involvement of glycoprotein C (gC) in adsorption of herpes simplex virus type 1 (HSV-1) to the cell. Arch. Virol. 120(3-4):1991;273-279.
44. Trybala E., Svennerholm B., Bergstrom T., Olofsson S., Jeansson S., Goodman J.L. Herpes simplex virus type 1-induced hemagglutination: glycoprotein C mediates virus binding to erythrocyte surface heparan sulfate. J. Virol. 67(3):1993;1278-1285.
45. Ugolini S., Mondor I., Parren P.W., Burton D.R., Tilley S.A., Klasse P.J., Sattentau Q.J. Inhibition of virus attachment to CD4+target cells is a major mechanism of T cell line-adapted HIV-1 neutralization. J. Exp. Med. 186(8):1997;1287-1298.
46. Webb L.M., Ehrengruber M.U., Clark Lewis I., Baggiolini M., Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA. 90(15):1993;7158-7162.
47. Witt D.P., Lander A.D. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4(5):1994;394-400.
48. Wu S.C., Spouge J.L., Merges M.J., Conley S.R., Nara P.L. A cytopathic infectivity assay of human immunodeficiency virus type 1 in human primary macrophages. J. Virol. Methods. 59(1-2):1996;45-55.
49. WuDunn D., Spear P.G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63(1):1989;52-58.
50. Yanagishita M., Salustri A., Hascall V.C. Specific activity of radiolabeled hexosamines in metabolic labeling experiments. Methods Enzymol. 179:1989;435-445.
51. Yura Y., Iga H., Kondo Y., Harada K., Tsujimoto H., Yanagawa T., Yoshida H., Sato M. Heparan sulfate as a mediator of herpes simplex virus binding to basement membrane. J. Invest. Dermatol. 98(4):1992;494-498.